Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
Go back to Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm| (NASDAQ: BBNX) | Delayed: 21.89 +0.46 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.43 | 52 Week High | $ | |||
| Open | $21.30 | 52 Week Low | $ | |||
| Day High | $22.16 | P/E | N/A | |||
| Day Low | $21.10 | EPS | $ | |||
| Volume | 2,204,829 | |||||
